Romlusevimab Biosimilar - Anti-Spike RBD mAb - Research Grade PX-TA1800-1MG from ProteoGenix

Supplier Page from
ProteoGenix for
Romlusevimab Biosimilar - Anti-Spike RBD mAb - Research Grade

ProteoGenix's Romlusevimab Biosimilar - Anti-Spike RBD mAb - Research Grade is a Human monoclonal antibody. The Romlusevimab Biosimilar - Anti-Spike RBD mAb - Research Grade Antibody was generated using S as the antigen. It reacts with 2019-nCoV, Corona Virus, Coronavirus, COVID-19, SARS-CoV-2, and Virus.

Product Specs
ItemRomlusevimab Biosimilar - Anti-Spike RBD mAb - Research Grade
CompanyProteoGenix
Price $1,428.00Supplier Page View Company Product Page
Catalog NumberPX-TA1800-1MG
Quantity1MG
Format0.01M PBS, pH 7.4
IsotypeIgG1, lambda2
HostHuman
TargetRBD
ReactivitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ClonalityMonoclonal Antibody
Storage4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles
Source/Expression SystemEukaryotic expression
NCBI Gene Aliasesspike glycoprotein

Add to Compare List

ProteoGenix

19 rue de la Haye

Schiltigheim 67300

France

Phone: +33 3 90 20 54 70
Fax : +33 3 88 56 16 88

Company Profile

Website: www.proteogenix.science

Be the First to Write a Review!

Romlusevimab Biosimilar - Anti-Spike RBD mAb - Research Grade from ProteoGenix

ProteoGenix

Reviews

Romlusevimab Biosimilar - Anti-Spike RBD mAb - Research Grade from ProteoGenix

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map